Vivere Oncotherapies Announces >$10M Funding to Develop Targeted Therapies for Solid Tumors

Jan 13

Written by Lara Wilson

Windfall Announces New Hires to Executive Leadership Team to Accelerate Next Phase of Growth

Encellin Announces Interim Clinical Results Showing First-in-Human Non-Fibrotic Engraftment and Viable Encapsulated Human Islets in Subjects with Type 1 Diabetes